Crossmark

Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells

Crossref DOI link: https://doi.org/10.1186/s40425-019-0751-5

Published Online: 2019-11-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bonanni, Valentina

Antonangeli, Fabrizio

Santoni, Angela

Bernardini, Giovanni https://orcid.org/0000-0002-3705-2598
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (21147)

Ministero dell’Istruzione, dell’Università e della Ricerca (20103FMJEN_001)
License Information

Text and Data Mining valid from 2019-11-07
More Information

Article History

Received: 23 May 2019

Accepted: 20 September 2019

First Online: 7 November 2019

Ethics approval and consent to participate

: All animal studies were approved by the Italian Ministry of Health (Health Ministry authorization 769/2015 PR and 30/2015 PR.

: Not applicable.

: The authors declare that they have no competing interests.